The use of electron impact and positive chemical ionization mass spectrometry in the screening of beta blockers and their metabolites in human urineLELOUX, M. S; MAES, R. A. A.Biomedical & environmental mass spectrometry. 1990, Vol 19, Num 3, pp 137-142, issn 0887-6134, 6 p.Article

Identification and determination of propafenone and its principal metabolites in human urine using capillary gas chromatography/mass spectrometryLELOUX, M. S; MAES, R. A. A.Biological mass spectrometry. 1991, Vol 20, Num 6, pp 382-388Article

Liver and gut mucosa acetylation of mesalazine in healthy volunteersVREE, T. B; DAMMERS, E; EXLER, P. S et al.International journal of clinical pharmacology and therapeutics. 2000, Vol 38, Num 11, pp 514-522, issn 0946-1965Article

Isolation and identification of the C₆-hydroxy and C₂₀-hydroxy metabolites and glucuronide conjugate of methylprednisolone by preparative high-performance liquid chromatography from urine of patients receiving high-dose pulse therapyVREE, T. B; WISSEN, C. P. W. G. M. V.-V; LAGERWERF, A. J et al.Journal of chromatography. B, Biomedical sciences and applications. 1999, Vol 726, Num 1-2, pp 157-168, issn 1387-2273Article

Flesinoxan pretreatment differentially affects corticosterone, prolactin and behavioural responses to a flesinoxan challengeGROENINK, L; VAN DER GUGTEN, J; COMPAAN, J. C et al.Psychopharmacologia. 1997, Vol 131, Num 1, pp 93-100, issn 0033-3158Article

Phase I clinical and pharmacokinetic study of topotecan administered by a 24-hour continuous infusionVAN WARMERDAM, L. J. C; TEN BOKKEL HUININK, W. W; RODENHUIS, S et al.Journal of clinical oncology. 1995, Vol 13, Num 7, pp 1768-1776, issn 0732-183XArticle

The secretion of propranolol enantiomers in human saliva : evidence for active transport ?HÖLD, K. M; DE BOER, D; SOEDIRMAN, J. R et al.Journal of pharmaceutical and biomedical analysis. 1995, Vol 13, Num 11, pp 1401-1407, issn 0731-7085Article

High-performance liquid chromatographic determination of metaiodobenzylguanidine in whole blood and plasma of cancer patientsWAFELMAN, A. R; KONINGS, M. C. P; ROSING, H et al.Journal of pharmaceutical and biomedical analysis. 1994, Vol 12, Num 9, pp 1173-1179, issn 0731-7085Article

High-performance liquid chromatography determination of m-iodobenzylguanidine in urine of cancer patientsWAFELMAN, A. R; NORTIER, Y. L. M; ROSING, H et al.Journal of chromatography. Biomedical applications. 1993, Vol 622, Num 1, pp 71-77, issn 0378-4347Article

Doping control of testosterone and human chorionic gonadotrophin : a case studyDE BOER, D; DE JONG, E. G; VAN ROSSUM, J. M et al.International journal of sports medicine. 1991, Vol 12, Num 1, pp 46-51, issn 0172-4622Article

Pharmacokinetics of morphine in cerebrospinal fluid and plasma after epidural administration in manDROST, R. H; IONESCU, T. I; TAVERNE, R. H. T et al.Arzneimittel-Forschung. 1988, Vol 38, Num 11, pp 1632-1634, issn 0004-4172, 3 p.Article

Terbutaline sustained-release treatment during one week 5 mg b.i.d. compared to one week placebo: terbutaline plasma levels, C-AMP plasma levels, lung function and tremor measurementVAN DERVET, A. P. H; KREUKNIET, J; DROST, R. H et al.International journal of clinical pharmacology, therapy and toxicology (1980). 1987, Vol 25, Num 11, pp 609-612, issn 0174-4879Article

measurement of flecainide plasma concentrations by high performance liquid chromatography with fluorescence detectionPLOMP, T. A; BOOM, H. T; MAES, R. A. A et al.Journal of analytical toxicology. 1986, Vol 10, Num 3, pp 102-106, issn 0146-4760Article

Lungfunction improvement, tremor measurements and c-AMP determinations in a group of ten patients with asthmatic bronchitis after one week sustained release theophylline medication (theophylline plasma level ± 10 mg/l) compared to one week placeboVAN DER VET, A. P. H; KREUKNIET, J; DROST, R. H et al.International journal of clinical pharmacology, therapy and toxicology (1980). 1986, Vol 24, Num 11, pp 638-642, issn 0174-4879Article

Determination of ethoheptazine in human post mortem materialDROST, R. H; BOELENS, M; MAES, R. A. A et al.Journal of chromatography. 1983, Vol 277, pp 352-355, issn 0021-9673Article

Development of a rapid and sensitive method for the quantitation of benzodiazepines in Calliphora vicina larvae and puparia by LC-MS-MSWOOD, M; LALOUP, M; PIEN, K et al.Journal of analytical toxicology. 2003, Vol 27, Num 7, pp 505-512, issn 0146-4760, 8 p.Article

Hyphenated techniques in anticancer drug monitoring. I. Capillary gas chromatography-mass spectrometryGUETENS, G; DE BOECK, G; WOOD, M et al.Journal of chromatography. 2002, Vol 976, Num 1-2, pp 229-238, issn 0021-9673, 10 p.Conference Paper

Simultaneous determination of the peptide-mitomycin KW-2149 and its metabolites in plasma by high-performance liquid chromatographyZHANG, Z. D; GUETENS, G; DE BOECK, G et al.Journal of chromatography. B, Biomedical sciences and applications. 2000, Vol 739, Num 2, pp 281-289, issn 1387-2273Article

Pharmacokinetics and bioavailability of oral 5'-deoxy-5-fluorouridine in cancer patientsVAN DER HEYDEN, S. A. M; HIGHLEY, M. S; DE BRUIJN, E. A et al.British journal of clinical pharmacology. 1999, Vol 47, Num 4, pp 351-356, issn 0306-5251Conference Paper

Discriminative stimulus properties of mCPP : evidence for a 5-HT_2C receptor mode of actionGOMMANS, J; HIJZEN, T. H; MAES, R. A. A et al.Psychopharmacologia. 1998, Vol 137, Num 3, pp 292-302, issn 0033-3158Article

Effects of 5-HT_1A receptor ligands in a modified Geller-Seifter conflict model in the ratKING, C. M. F; GOMMANS, J; JOORDENS, R. J. E et al.European journal of pharmacology. 1997, Vol 325, Num 2-3, pp 121-128, issn 0014-2999Article

Formation of chloroethylamine and 1,3-oxazolidine-2-one following ifosfamide administration in humansHIGHLEY, M. S; MOMERENCY, G; VAN CAUWENBERGHE, K et al.Drug metabolism and disposition. 1995, Vol 23, Num 3, pp 433-437, issn 0090-9556Article

Monitoring carboplatin concentrations in saliva : a replacement for plasma ultrafiltrate measurements ?VAN WARMERDAM, L. J. C; VAN TELLINGEN, O; TEN BOKKEL HUININK, W. W et al.Therapeutic drug monitoring. 1995, Vol 17, Num 5, pp 465-470, issn 0163-4356Article

Pharmacokinetics and pharmacodynamics of topotecan administered daily for 5 days every 3 weeksVAN WARMERDAM, L. J. C; VERWEIJ, J; SCHELLENS, J. H. M et al.Cancer chemotherapy and pharmacology. 1995, Vol 35, Num 3, pp 237-245, issn 0344-5704Article

Validation of a limited sampling model for carboplatin in a high-dose chemotherapy combinationVAN WARMEDAM, L. J. C; RODENHUIS, S; VAN TELLINGEN, O et al.Cancer chemotherapy and pharmacology. 1994, Vol 35, Num 2, pp 179-181, issn 0344-5704Article